MESOTELIOMA

Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.

Promotor: ETOP
Coordinador en España: Dr. Ernest Nadal

Centros participantes

• Institut Català d’Oncologia-Hospitalet
• Hospital Clínico Universitario de Valladolid
• Hospital Teresa Herrera, A Coruña